Rocio Rubio
Overview
Explore the profile of Rocio Rubio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rubio R, Yavlinsky A, Escalera Zamudio M, Molinos-Albert L, Martin Perez C, Pradenas E, et al.
J Infect
. 2025 Jan;
90(2):106402.
PMID: 39746406
Objectives: We aimed to evaluate the adaptive immune responses cross-recognition of the hypermutated SARS-CoV-2 BA.2.86 variant and identify the determinants influencing this recognition. Methods: We measured BA.2.86 neutralizing antibodies and...
2.
Karachaliou M, Espinosa A, Farre X, Blay N, Castano-Vinyals G, Iraola-Guzman S, et al.
Vaccine
. 2024 Dec;
45():126591.
PMID: 39671776
Methods: The association between mental illness diagnoses (mood affective disorders, anxiety disorders, other) over ten years and psychotropic drug prescription based on electronic health records with antibody levels (IgG and...
3.
Rubio R, Macia D, Barrios D, Vidal M, Jimenez A, Molinos-Albert L, et al.
Microbes Infect
. 2024 Sep;
27(2):105423.
PMID: 39299570
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) studies usually rely on cross-sectional data of large cohorts but limited repeated samples, overlooking significant inter-individual antibody kinetic differences. By combining Luminex, activation-induced...
4.
Martin Perez C, Aguilar R, Jimenez A, Salmeron G, Canyelles M, Rubio R, et al.
BMC Med
. 2024 Mar;
22(1):103.
PMID: 38454385
Background: The emergence of new SARS-CoV-2 variants and the waning of immunity raise concerns about vaccine effectiveness and protection against COVID-19. While antibody response has been shown to correlate with...
5.
Kogevinas M, Karachaliou M, Espinosa A, Aguilar R, Castano-Vinyals G, Garcia-Aymerich J, et al.
Environ Health Perspect
. 2023 Apr;
131(4):47001.
PMID: 37017430
Background: Ambient air pollution has been associated with COVID-19 disease severity and antibody response induced by infection. Objectives: We examined the association between long-term exposure to air pollution and vaccine-induced...
6.
Aguilar R, Li X, Crowell C, Burrell T, Vidal M, Rubio R, et al.
Microbiol Spectr
. 2023 Jan;
11(1):e0316522.
PMID: 36622140
The ability of antibodies to neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an important correlate of protection. For routine evaluation of protection, however, a simple and cost-efficient anti-SARS-CoV-2...
7.
Rubio R, Aguilar R, Bustamante M, Munoz E, Vazquez-Santiago M, Santano R, et al.
Front Immunol
. 2022 Oct;
13:999136.
PMID: 36238312
SARS-CoV-2 infected pregnant women are at increased risk of severe COVID-19 than non-pregnant women and have a higher risk of adverse pregnancy outcomes like intrauterine/fetal distress and preterm birth. However,...
8.
Dobano C, Ramirez-Morros A, Alonso S, Rubio R, Ruiz-Olalla G, Vidal-Alaball J, et al.
BMC Med
. 2022 Oct;
20(1):379.
PMID: 36224590
This study evaluated the persistence of IgM, IgA, and IgG to SARS-CoV-2 spike and nucleocapsid antigens up to 616 days since the onset of symptoms in a longitudinal cohort of...
9.
Karachaliou M, Moncunill G, Espinosa A, Castano-Vinyals G, Rubio R, Vidal M, et al.
BMC Med
. 2022 Sep;
20(1):347.
PMID: 36109713
Background: Heterogeneity of the population in relation to infection, COVID-19 vaccination, and host characteristics is likely reflected in the underlying SARS-CoV-2 antibody responses. Methods: We measured IgM, IgA, and IgG...
10.
Dobano C, Ramirez-Morros A, Alonso S, Ruiz-Olalla G, Rubio R, Vidal M, et al.
Immunology
. 2022 Sep;
167(4):528-543.
PMID: 36065677
We evaluated the kinetics of antibody responses to Two years into the COVID-19 pandemic and 1 year after the start of vaccination rollout, the world faced a peak of cases...